| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 04/16/2009 | CA2702103A1 Improvements in or relating to amphotaric liposomes comprising neutral lipids |
| 04/16/2009 | CA2700824A1 Heterocyclic compounds as crth2 receptor antagonists |
| 04/16/2009 | CA2699257A1 Cgrp as a therapeutic agent |
| 04/16/2009 | CA2699169A1 Therapeutic uses of intermedin 47 and 53 peptides |
| 04/16/2009 | CA2699168A1 Use of the peptide thymosin beta 4 alone or in combination with cecropin a as a therapeutic agent |
| 04/16/2009 | CA2699163A1 Use of a peptide as a therapeutic agent |
| 04/16/2009 | CA2699088A1 Use of a peptide as a therapeutic agent |
| 04/16/2009 | CA2699084A1 Use of cnp-22, alone1 or in combination with physalemin, as a therapeutic agent |
| 04/16/2009 | CA2699083A1 Use of a peptide as a therapeutic agent |
| 04/15/2009 | EP2048163A1 Antihuman alpha- 9 integrin antibody and use of the same |
| 04/15/2009 | EP2048142A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof |
| 04/15/2009 | EP2047863A1 Preventive or remedy for inflammatory disease |
| 04/15/2009 | EP2046835A2 Antibodies to il-17a |
| 04/15/2009 | EP2046834A1 Monoclonal antibodies against stromal derived factor-1 (sdf-1) |
| 04/15/2009 | EP2046778A1 Multifunctional bioactive compounds |
| 04/15/2009 | EP2046759A1 2, 4 -di (arylaminio) -pyrimidine-5-carboxamide compounds as jak kinases inhibitors |
| 04/15/2009 | EP2046746A2 Chemical compounds |
| 04/15/2009 | EP2046740A1 Compounds having crth2 antagonist activity |
| 04/15/2009 | EP2046365A1 Pharmaceutical composition for treating autoimmune, allergic and inflammatory diseases and delivery method thereof |
| 04/15/2009 | EP2046351A2 Adult sertoli cells and uses thereof |
| 04/15/2009 | EP2046338A2 Pharmaceutical formulations comprising azelastine and a corticosteroid for the treatment of inflammatory or allergic conditions |
| 04/15/2009 | EP2046333A2 Thiozolidinedione derivatives as p13 kinase inhibitors |
| 04/15/2009 | EP2046332A2 Concentrated methotrexate solutions |
| 04/15/2009 | EP2046311A2 Dioxo-alkanes and dioxo-alkenes |
| 04/15/2009 | EP2046309A2 Use of vitamin d3 agonist in a mammalian model for atopic diseases and of vitamin d3 antagonists for the treatment of atopic diseases |
| 04/15/2009 | EP1690549B1 Immunotherapic agent which is used for the combined treatment of tuberculosis together with other pharmaceuticals |
| 04/15/2009 | EP1551763B1 Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate |
| 04/15/2009 | EP1519731B1 Combination of azelastine and fluticasone |
| 04/15/2009 | EP1505148B1 Methods of screening for agonistic antibodies |
| 04/15/2009 | EP1428536B1 Remedies or preventives for allergic diseases comprising processed peanut seed coat |
| 04/15/2009 | EP1406599B1 Cosmetic and dermatological preparations containing creatine for treating and actively preventing dry skin and other negative alterations of the physiological homeostasis of healthy skin |
| 04/15/2009 | EP1363635B1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 04/15/2009 | EP1311532B1 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase |
| 04/15/2009 | EP1079854B1 Compositions and methods of modulating an immune response to an antigen by administration of cytokine-coated cells |
| 04/15/2009 | EP1043317B1 Pyridazine derivatives and medicaments containing them as active ingredient |
| 04/15/2009 | EP1012267B1 An antisense oligonucleotide preparation method |
| 04/15/2009 | CN101410130A Novel immunomodulating peptide |
| 04/15/2009 | CN101410122A Method and composition for treating anaphylactic disease |
| 04/15/2009 | CN101410114A A3 adenosine receptor allosteric modulators |
| 04/15/2009 | CN101410107A MIF inhibitors |
| 04/15/2009 | CN101407812A Heterologous expression and purification method for human RANTES protein having chemotaxis |
| 04/15/2009 | CN101407796A Recombinant alpha-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof |
| 04/15/2009 | CN101407558A Preparation of Dendrobium nobile polysaccharide extract and use there |
| 04/15/2009 | CN101407557A Preparation and use of Dendrobium nobile polysaccharide extract |
| 04/15/2009 | CN101407554A Sodium carboxymethylstarch and preparation thereof |
| 04/15/2009 | CN101407471A Compound capable of binding S1P receptor and pharmaceutical use thereof |
| 04/15/2009 | CN101406683A Chinese medicine compound and preparation method thereof |
| 04/15/2009 | CN101406677A Medicinal liquor having function for warming and invigorating kidney yang |
| 04/15/2009 | CN101406660A Medicament for improving organism immunity of aquatic livestock |
| 04/15/2009 | CN101406600A External-use Chinese medicinal ointment for treating eczema and preparation method thereof |
| 04/15/2009 | CN101406571A Medicament with health-care function |
| 04/15/2009 | CN101406563A Oral liquid for improving immunity of human body |
| 04/15/2009 | CN101406545A Rosa roxburghii soft capsule and preparation method thereof |
| 04/15/2009 | CN101406544A Rosa roxburghii oral liquid and preparation method thereof |
| 04/15/2009 | CN101406525A Chinese medicine feedstuff additive for immunity enhancement of fowl |
| 04/15/2009 | CN101406494A Chinese medicinal composition, preparation method and application |
| 04/15/2009 | CN101406493A Microsphere for injection of Cordyceps sinensis and preparation method thereof |
| 04/15/2009 | CN101406492A Compound Cordyceps sinensis oil soft capsule and preparation technique |
| 04/15/2009 | CN101406491A Oil-in-water Cordyceps sinensis emulsion and preparation technique |
| 04/15/2009 | CN101406486A Method for preparing maggot health-care oral liquid |
| 04/15/2009 | CN101406476A Agent for treating skin peeling and allergy |
| 04/15/2009 | CN101406453A Pharmaceutical compositions for oral and topical administration |
| 04/15/2009 | CN101406452A Ciclosporin A microemulsion formulation for injection and preparation method thereof |
| 04/15/2009 | CN101406248A Nonspecific immunity strengthening agent for shrimps and crabs, and preparation method thereof |
| 04/15/2009 | CN100478031C The use of substituted tetracyclic imidazole derivatives as anti-histaminics |
| 04/15/2009 | CN100478029C Immunomodulatory human MHC class II antigen-binding polypeptides |
| 04/15/2009 | CN100478026C Delivery system for biological component |
| 04/14/2009 | US7517989 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 04/14/2009 | US7517987 Interleukin converting enzyme inhibitors such as 5-Fluoro-4-oxo-3-(2-(6-oxo-6H-pyrimidin-1-yl)-butyrylamino)-pentanoic acid, administered as modulators of cell apoptosis and inflammation |
| 04/14/2009 | US7517967 Monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma |
| 04/14/2009 | US7517962 TWEAK receptor |
| 04/14/2009 | US7517907 specific activator of retinoic acid receptors subtype beta; 6-[3-adamantan-1-yl-4-(2,2-dimethyl[1,3]dioxoian-4-ylmethoxy)phenyl]naphthalene-2-carboxylic acid; useful in human or veterinary medicine; for body/hair hygiene, treating acne-prone skin, promoting hair regrowth, limiting hair loss, dry skin |
| 04/14/2009 | US7517886 Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds |
| 04/14/2009 | US7517875 Piperidine derivatives having CCR3 antagonism |
| 04/14/2009 | US7517861 Containing unmethylated CpG dinucleotides; redirection of a Th2 response to a Th1 response; atopic diseases, dermatitis |
| 04/14/2009 | US7517661 Methods of screening for ligands for FPRL2 |
| 04/14/2009 | US7517658 Drug screening for human SNORF33 receptor agonist by contacting cells transfected with and expressing DNA encoding the human SNORF33 receptor, wherein cells prior to being transfected with the DNA do not express the human SNORF33 receptor; inflammation, infections, arthritis; autoimmune diseases |
| 04/14/2009 | US7517529 Using gene-regulatory peptide |
| 04/14/2009 | US7517524 Monoclonal antibody or an antigen-binding fragment thereof which binds to human VEGF-B (vascular endothelial growth factor) produced by hybridoma; neovascularization diseases; antitumor, anticarcinogenic, antiinflammatory, and antimetastasis agents; rheumatoid arthritis; angiogenesis inhibitors |
| 04/14/2009 | CA2530474C Remedy for sarcoidosis and method of treating the same |
| 04/14/2009 | CA2427817C Estrone-derivatives having cytoprotective activity |
| 04/14/2009 | CA2417050C Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
| 04/14/2009 | CA2389111C Novel combination of loteprednol and .beta.2-adrenoceptor agonists |
| 04/14/2009 | CA2359440C Phenylphenanthridines with pde-iv inhibiting activity |
| 04/14/2009 | CA2355341C The use of ara as a supplement for a lactating woman |
| 04/14/2009 | CA2232378C Aerosol compositions |
| 04/09/2009 | WO2009045497A1 Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides |
| 04/09/2009 | WO2009045313A2 Oxypiperidine derivatives as histamine receptor antagonists |
| 04/09/2009 | WO2009044899A1 Nucleic acid capable of regulating the proliferation of cell |
| 04/09/2009 | WO2009044788A1 Benzoxazinone derivative |
| 04/09/2009 | WO2009044774A1 Remedy for graft-versus-host disease comprising interleukin-6 receptor inhibitor as the active ingredient |
| 04/09/2009 | WO2009044273A2 Use of recombinant lag-3 or the derivatives thereof for eliciting monocyte immune response |
| 04/09/2009 | WO2009043890A1 Oxadiazole diaryl compounds |
| 04/09/2009 | WO2009043889A2 Oxadiazole derivatives |
| 04/09/2009 | WO2009043529A1 Thyrotropin releasing hormone for therapeutic applications |
| 04/09/2009 | WO2009043528A1 Substance p and thyrotropin releasing hormone for therapeutic applications |
| 04/09/2009 | WO2009043525A2 Use of the combination of gluten exorphin c and cd36 as a therapeutic agent |
| 04/09/2009 | WO2009043524A2 Use of a peptide as therapeutic agent |
| 04/09/2009 | WO2009043523A2 Cortistatin 17 and neuropeptide 1 for use as therapeutic agent |
| 04/09/2009 | WO2009043522A2 Use of a peptide as a therapeutic agent |